Karen Massey

Life sciences

Now Chief Executive Officer · argenx

Latest on AI4S.fyi

TIMELINE · 2026-11-09

argenx agrees to buy Unnatural Products, which designs ring-shaped peptide drugs with machine learning and parallel chemistry, for $550 million upfront and up to about $1.15 billion

Path

AR
argenxChief Executive Officer

On the timeline

2026-11-09argenx agrees to buy Unnatural Products, which designs ring-shaped peptide drugs with machine learning and parallel chemistry, for $550 million upfront and up to about $1.15 billion

Sourcessec.gov

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →